. Binding of LATS by HTP was inhibited by serum 1, indicating presence ofLATS-protector. Serum I didnot contain detectable LATS. Serum 2 contained neither LATS norLATSprotector laboratories is probably an indication of the importance of establishing suitable assay conditions. Fig 1 demonstrates , in a representative experiment, that the amount of HTP added should almost, but not entirely, neutralize the LATS activity. When the mixture of LATS+ HTP+serum 1 was assayed, thyroid stimulation resulted, indicating the presence of LATSprotector, whereas serum 2 did not contain demonstrable LATS-protector. The sensitivity of detection of LATS-protector is improved when the LATS negative serum is preincubated with HTP before the addition of LATS, but the temperature for preincubation is not critical.
Using this method, LATS-protector can be detected in unconcentrated serum from the majority of patients with Graves' disease (see Table 1 ) and is found in a much higher proportion than is LATS; it has been found in serum ofpatients receiving carbimazole. It has not been found in serum or in immunoglobulin concentrates from 32 normal subjects, in 14 patients with nontoxic nodular goitre or 12 with Hashimoto's disease, nor in 4 patients whose disease appears to have remitted. It is sometimes possible to demonstrate LATS-protector in serum which also contains LATS. It is clear then that LATS-protector is closely associated with Graves' disease. It interacts specifically with human thyroid tissue; unlike LATS it neither binds to, nor stimulates, the mouse thyroid.
Recent work has been directed to determining whether LATS-protector stimulates the human thyroid. Thyrotoxic LATS-negative Ig did not activate human thyroid adenycyclase whereas LATS did (Kendall-Taylor 1973 ) but, in contrast to this, Onaya et al. (1973 found that LATSnegative serum stimulated cyclic AMP accumulation in thyroid slices in vitro. They also found, as did Shishiba et al. (1973) , an increase in colloid droplet formation. However, the most definitive evidence is the personal observation of Adams that injection ofLATS-protector increased thyroid function of man in vivo (Adams et al. 1974) .
The evidence strongly suggests that hyperthyroid serum contains an IgG distinct from, and perhaps additional to, LATS, which stimulates the human thyroid. This is probably the same as LATS-protector and might better be termed human-specific thyroid stimulator. Autoimmunity to Sperm Experience from animal experiments suggests that autoimmunity to spermatozoal antigens includes two main aspects: lesions in the spermproducing tissue in the testes and immune reactions affecting spermatozoa in the seminal plasma. However, in man the existence of a naturally occurring autoimmune orchitis has never been proved. Furthermore the role played by cell-mediated immunity has not been clarified, so that the discussion may be limited to the question of spermatozoal antibodies in serum and seminal plasma.
Methodsfor Detection ofAntibodies against Spermatozoal Antigens
The various autoantigens in human spermatozoa have not yet been isolated and characterized. Sperm-immunology is therefore still at the immature stage, where most antibodies are named by the methods used for their detection. The macroscopic sperm-agglutination test (Kibrick et al. 1952) , which seems the most useful method for detection of spermatozoal antibodies in men, appears to involve several antigen-antibody systems as indicated by the different agglutination patterns (head-to-head, tail-to-tail, tail tip-to-tail tip and mixed type). The microscopic spermagglutination test (Franklin & Dukes 1964 ) may also reveal antibodies, but the studies of Boettcher & Kay (1969) indicate that a ,8-lipoprotein may also cause microagglutination. When only the immunological aspects are discussed, the results with this technique should therefore be taken with great reservation. The immobilization test and the cytotoxicity testboth requiring complementapparently reveal the same antibodies. Sera with high concentrations of sperm agglutinins (in the Kibrick test) are usually also immobilizing and cytotoxic, but such effects have also been observed with non-agglutinating sera.
All these techniques seem to involve antigens in the cell membrane of the spermatozoa. Immunofluorescent technique with fixed spermatozoa (Hjort & Hansen 1971) or with trypsintreated swollen sperm heads (Kolk et al. 1974) can on the other hand disclose antibodies to antigens beneath the cell membrane. With methanol-fixed spermatozoa it is possible to detect antibodies against the entire acrosome, the front part of the acrosome, the equatorial segment, the post-nuclear cap and the main tail piece.
Occurrence ofSperm Antibodies
High concentrations of sperm agglutinins, detected by the Kibrick test, have been found significantly more frequently in serum in men from infertile couples (in 3-4%) than in fertile men (in less than 1 %) (Rumke & Hellinga 1959, Fjallbrant 1968), and titres > 64 have been assumed to imply reduced fertility.
We have recently examined sera from 559 men from infertile couples by means of the Kibrick agglutination test and immunofluorescent technique. The men were divided into three groups: Group 1, where anatomical or hormonal abnormalities in the woman seemed to explain the infertility (the man being apparently normal), Group 2 where similar abnormalities were found in the man; and Group 3 where the infertility remained 'unexplained'. The results (Table 1) show that sperm agglutinins occurred significantly more frequently in Group 3 than in Groups 1 and 2. Antibodies, detected by immunofluorescence, were also more common in Groups 3 and 2 than in Group 1, particularly in titres > 30. The findings were, however, rather scarce, and the increased antibody frequencies in Group 3, compared with Group 1, were of statistical significance only for antibodies against the equatorial segment and the main tail piece.
From a pathogenic point of view only sperm antibodies in seminal plasma would seem of significance. Sperm agglutinins in serum have, however, on a rather weak theoretical basis, been taken as a more convenient parameter for agglutinins in seminal plasma. Routine testing of both serum and seminal plasma from 251 of our patients revealed that sperm agglutinins were found in seminal plasma only when they were also present in serum. Generally the titres in seminal plasma were slightly lower than in serum, but there was no close correlation.-Three patients with high titres of sperm agglutinins in serum, who turned out to be fertile, all had low titres in seminal plasma, whereas none of our patients with high titres in seminal plasmaand with spontaneous agglutination in the ejaculatehas proved to be fertile. Of the immunofluorescent antibodies only antibodies against the equatorial segment have been detected in seminal plasma, and only in a few patients.
The assumption that autoimmunity to spermatozoa is elicited by extravasation of spermatozoal antigens has recently gained support from the (Ansbacher 1971 , Shulman et al. 1972 . It now appears, that testis biopsy may also elicit weak -immune responses. Thus, within six weeks after testis biopsy, an increase in the titre of preexisting antibody or appearance of a new antibody was observed in 11 of 35 patients, but the various antigens differed in stimulating potency. Sperm agglutinins appeared in 6 patients, and a response to the antigen in the main tail piece was noticed in 8 patients. The antigens in the front part of the acrosome and the equatorial segment affected 4 and 3 patients respectively, and for the antigen in the postnuclear cap no stimulatory effect was observed (Hjort et al. 1974 ). Irvine The essential pathology of the pancreas in juvenile diabetes mellitus is a gross reduction of islet tissue. In maturity onset diabetes there is moderate reduction of islet tissue and a varied degree of hyalinization of islets. In the search for histological clues to the pathogenesis of juvenile diabetes, old post-mortem material from preinsulin days has been reexamined by a number of authors (Maclean & Ogilvie 1955 , Gepts 1965 , Warren et al. 1966 , Doniach & Morgan 1973 . In the series reported by Gepts (1965) the pancreas of patients dying within days or weeks of abrupt clinical onset showed reduction of number of islets, with some of the surviving islets hypertrophied, others shrunken and devoid of betacell granulation. He noted the presence of insulitis, infiltration of the islets by lymphocytes, in 15 of 22 cases.
Post-mortem pancreas sections were examined (Doniach & Morgan 1973) from 13 untreated juvenile diabetics 9 of whom had died within 1 to 4 weeks of clinical onset, 13 insulin treated juvenile diabetics who had survived 6 to 38 years and matched non-diabetic controls for both groups. The findings are shown in Table 1 . We confirmed most of Gepts's (1965) findings: loss of islets and beta-granulated cells in acute cases with further loss in chronic cases. However, there was not a single example of insulitis in any of our material, suggesting that its incidence is less frequent than previously postulated.
The occurrence of insulitis in acute rapidly fatal cases of juvenile diabetes affecting children has been repeatedly documented since its original description by Schmidt in 1902. The affected islets, usually atrophic, are infiltrated most commonly by lymphocytes arranged as a peripheral extra-and intra-insular collar, but sometimes diffusely through the islet tissue. Large mononuclears, polymorphs or eosinophils may be included in the infiltrate but not plasma cells. The intensity of the insulitis varies considerably between cases, sometimes involving only very few islets (Gepts 1965). Gepts found no insulitis in chronic juvenile diabetes. Recently LeCompte & Legg (1972) have reported two examples of its occurrence in adults with maturity onset diabetes.
From the pathological point of view speculation on etiological factors in acute juvenile diabetes must account for dramatic reduction in number of islets in spite of a short clinical
